Investing.com - Harrow Health (NASDAQ:HROW) reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Harrow Health announced earnings per share of $-0.240 on revenue of $22.8M. Analysts polled by Investing.com anticipated EPS of $-0.010 on revenue of $23.14M.
Harrow Health shares are down 63% from the beginning of the year, still down 12.69% from its 52 week high of $13.29 set on October 3.
Harrow Health follows other major Healthcare sector earnings this month
Harrow Health's report follows an earnings beat by J&J on October 18, who reported EPS of $2.55 on revenue of $23.79B, compared to forecasts EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on November 1 with third quarter EPS of $1.98 on revenue of $6.94B, compared to forecast for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar